Palantir reported revenues of $322 million for the fourth fiscal quarter, topping the $300.7 million consensus. It had an adjusted EPS of 6 cents, higher than the 2 cents projected by analysts. In the past quarter, it closed deals with the FDA, PG&E, and the US army.
Overall, in 2020 announced a revenue per customer of $7.9 million, 41% higher than that reported in 2019. Also, its top 20 customers generated revenues 34% higher than the previous year, figures reaching $33.2 million.
For the quarter ending in March, Palantir expects its revenue to increase 45%, while analysts are looking for a 35% growth to $309.5 million.
However, for 2021 the revenue growth is seen lower than in 2020, at 30%.
Following the news, Palantir stock price fell 12.8%.
Stay updated with the latest financial news with CAPEX.com!
Sources: cnbc.com, investors.com